Medpace Holdings, Inc.
NASDAQMedpace Holdings heads into its July 22 earnings print with the Street turning more cautious just days before results — and two back-to-back downgrades in two days are the defining story this week. The analyst moves are striking in their timing and their structure. Jefferies analyst David Windley cut his rating from Buy to Hold on July 7, raising his target from $490 to $515…
Snapshot as of 8 Jul 2026
Medpace Holdings heads into its July 22 earnings print with the Street turning more cautious just days before results — and two back-to-back downgrades in two days are the defining story this week. The analyst moves…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MEDP — free to start on ORTEX.
Sign up for free →Open MEDP on ORTEX